Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Xeris Pharmaceuticals Inc (NQ: XERS )

4.230 USD -0.030 (-0.70%)
Official Closing Price Updated: 7:57 PM EDT, Apr 9, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Xeris Pharmaceuticals Inc

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Xeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable and infusible drug... 
From Business Wire News Releases
Xeris Pharmaceuticals Becomes Oversold (XERS)
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a... 
Tags Stocks
From Market News Video
NASDAQ:XERS Shareholder Notice: Investigation over Possible Securities Laws Violations by Xeris Pharmaceuticals, Inc.
San Diego, CA -- (SBWIRE) -- 03/22/2021 -- Xeris Pharmaceuticals, Inc. is under investigation concerning potential violations of securities laws in connection with certain financial statements. 
From SBWire - Latest Press Releases
Interesting XERS Call Options For May 21st
Investors in Xeris Pharmaceuticals Inc (XERS) saw new options become available this week, for the May 21st expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the XERS... 
Tags Stocks
From Market News Video
3 Penny Stocks To Watch Today After Big News This Week
Tags Market News
From Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
Iterum Therapeutics Appoints Beth P. Hecht to Board of Directors
From GlobeNewswire News Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Xeris Pharmaceuticals, Inc. - XERS
Pomerantz LLP is investigating claims on behalf of investors of Xeris Pharmaceuticals, Inc. ("Xeris" or the "Company") (NASDAQ: XERS). Such investors are advised to contact Robert S. Willoughby at... 
From PR Newswire
Xeris Pharmaceuticals Announces Pricing of $27.0 Million Registered Direct Offering
Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel formulation technology platforms to develop and commercialize ready-to-use injectable and infusible... 
From Business Wire News Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Xeris Pharmaceuticals, Inc. - XERS
Pomerantz LLP is investigating claims on behalf of investors of Xeris Pharmaceuticals, Inc. ("Xeris" or the "Company") (NASDAQ: XERS). Such investors are advised to contact Robert S. Willoughby at... 
From PR Newswire
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers INVO Bioscience (NASDAQ:INVO) shares increased by 183.59% to $8.82 during Tuesday's regular session. INVO ... 
Tags SLS EARS ANPC
From Benzinga
61 Stocks Moving In Tuesday's Mid-Day Session
Gainers INVO Bioscience, Inc. (NASDAQ: INVO) shares jumped 230.6% to $10.28 after the company announced an amendment under its ... 
Tags EYES DISCA MTLS
From Benzinga
Why Xeris Pharmaceuticals Is Trading Lower Today
Xeris Pharmaceuticals's Stock Price And Volume Action Xeris Pharmaceuticals's (NASDAQ:XERS) stock has been falling Tuesday, ... 
Tags Trading Ideas BZI/WIIM Market News
From Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers AnPac Bio-Medical Science (NASDAQ:ANPC) shares increased by 72.24% to $9.99 during Tuesday's pre-market ... 
Tags SURF Markets INVO
From Benzinga
The Daily Biotech Pulse: Regulatory Setback For Acadia, Lilly Forges Diabetes Antibody Treatment Collaboration, Aytu's Positive COVID-19 Data
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags Penny Stocks NARI XERS
From Benzinga
Xeris Pharmaceuticals Reports Fourth Quarter and Full-year 2020 Financial Results and Recent Highlights
Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel formulation technology platforms to develop and commercialize ready-to-use injectable and infusible... 
From Business Wire News Releases
Earnings Scheduled For March 9, 2021
Companies Reporting Before The Bell • Barnes & Noble Education (NYSE:BNED) is expected to report quarterly loss at ... 
Tags CREX Earnings Scheduled BZI/UE
From Benzinga
Earnings Outlook for Xeris Pharmaceuticals
Xeris Pharmaceuticals (NASDAQ:XERS) unveils its next round of earnings this Tuesday, March 09. Get prepared with Benzinga's ultimate ... 
Tags Market News XERS Benzinga
From Benzinga
The Week Ahead In Biotech (March 7-13): Conference Presentations And More Earnings
Biotech stocks continued to move southward in the week ended March 5, as the broader market extended its sell-off. Though light on news, ... 
Tags DRIO BDSI HARP
From Benzinga
Xeris Pharmaceuticals Breaks Below 200-Day Moving Average - Notable for XERS
In trading on Thursday, shares of Xeris Pharmaceuticals Inc (XERS) crossed below their 200 day moving average of $4.80, changing hands as low as $4.68 per share. Xeris Pharmaceuticals Inc shares are... 
Tags Stocks
From Market News Video
Xeris Pharmaceuticals to Announce Fourth Quarter and Full Year 2020 Financial Results and Host Conference Call and Webcast on March 9, 2021
Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel formulation technology platforms to develop and commercialize ready-to-use injectable and infusible... 
From Business Wire News Releases
Attention Biotech Investors: Mark Your Calendar For March PDUFA Dates
Most Food and Drug Administration decisions scheduled for February were positive, and more importantly five new molecular entities ... 
Tags BMY AVEO Biotech
From Benzinga
Xeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable and infusible drug... 
From Business Wire News Releases
Xeris Pharmaceuticals to Webcast Upcoming Investor Conference Presentations
Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable and infusible drug... 
From Business Wire News Releases
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Artelo Biosciences (NASDAQ:ARTL) shares rose 61.34% to $2.63 during Friday's pre-market session. The company's market cap ... 
Tags ARTL Health Care Trading Ideas
From Benzinga
Thinking about buying stock in Artelo Biosciences, Xeris Pharmaceuticals, Inovio Pharmaceuticals, Novan, or Fisker?
InvestorsObserver issues critical PriceWatch Alerts for ARTL, XERS, INO, NOVN, and FSR. 
From PR Newswire
The Daily Biotech Pulse: European Regulatory Nod For Xeris, Amicus Falls On Data, 4 IPOs, FDA Decision For Mallinckrodt's StrataGraft Delayed
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags VLON MEDP AYTU
From Benzinga
Xeris Pharma's Hypoglycemia Med Receives European Nod, Shares Spike
TheEuropean Commission has approvedXeris Pharmaceuticals Inc's(NASDAQ:XERS) Ogluo (glucagon) injection to ... 
Tags News General hypoglycemia
From Benzinga
Xeris Pharmaceuticals Receives European Commission Approval of Ogluo™ (glucagon) Injection for the Treatment of Severe Hypoglycaemia in Adults, Adolescents, and Children Aged 2 Years and Over With Dia
Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel formulation technology platforms to develop and commercialize ready-to-use injectable and infusible... 
From Business Wire News Releases
The Daily Biotech Pulse: Dynavax Poaches GSK Vaccine Exec, KalVista Jumps On Data Readout, Corcept Issues Negative Preannouncement
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags COLL BEAM SESN
From Benzinga
Stocks That Hit 52-Week Highs On Monday
Monday morning saw 558 companies set new 52-week highs. Noteables: The largest company on a market cap ... 
Tags Intraday Update Trading Ideas WBAI
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.